Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2016
PAK1 Is a Novel Therapeutic Target in Tyrosine Kinase Inhibitor-Resistant Lung Adenocarcinoma Activated by the PI3K/AKT Signaling Regardless of EGFR MutationDe-Wei Wu, Tzu-Chin Wu, Chih-Yi Chen, et al.
Oncotarget|April 1, 2015
Paxillin promotes colorectal tumor invasion and poor patient outcomes via ERK-mediated stabilization of Bcl-2 protein by phosphorylation at Serine 87Chi-Chou Huang, De-Wei Wu, Po-Lin Lin, et al.
Cancer Research|December 17, 2010
Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targetingDe-Wei Wu, Ya-Wen Cheng, John Wang, et al.
Theranostics|March 7, 2018
A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loopDe-Wei Wu, Yao-Chen Wang, Lee Wang, et al.
Theranostics|April 25, 2017
The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancerDe-Wei Wu, Po-Lin Lin, Lee Wang, et al.
Scientific Reports|October 24, 2020
Author Correction: PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemnessMing-Jenn Chen, De-Wei Wu, Yao-Chen Wang, et al.
Pathology, Research and Practice|January 28, 2019
Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancerMing-Jenn Chen, Yao-Chen Wang, De-Wei Wu, et al.
Free Radical Biology & Medicine|April 2, 2016
Cytoplasmic localization of Nrf2 promotes colorectal cancer with more aggressive tumors via upregulation of PSMD4Po-Lin Lin, Jinghua Tsai Chang, De-Wei Wu, et al.
Surgery|February 25, 2018
Hepatitis B virus X protein represses LKB1 expression to promote tumor progression and poor postoperative outcome in hepatocellular carcinomaCheng-Chung Wu, De-Wei Wu, Ying-Yu Lin, et al.
Scientific Reports|October 8, 2016
PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemnessMing-Jenn Chen, De-Wei Wu, Yao-Chen Wang, et al.
Pageof 4